KRYS
Krystal Biotech, Inc. Common Stock
NasdaqGSUSDEQUITY
DELAYED
Last price
346.58
▲ 9.56 (2.84%)
MARKET · —
Price
Open
337.03
Prev close
337.02
Day high
347.92
Day low
335.72
Volume
407.79K
Market cap
—
P/E (TTM)
—
52W range
136.73 – 382.54
Trailing performance
Returnvs SPY
1W
+4.31%
+5.7%
1M
+5.83%
+2.1%
3M
+13.92%
+10.8%
6M
+32.38%
+21.3%
YTD
+40.58%
+28.3%
1Y
+137.61%
+117.6%
3Y
+184.08%
+109.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
334.76
+3.53% from price
SMA 20
337.36
+2.73% from price
SMA 50
345.35
+0.36% from price
SMA 100
315.60
+9.82% from price
SMA 200
282.49
+22.69% from price
EMA 12
336.79
+2.91% from price
EMA 26
337.91
+2.57% from price
EMA 50
334.62
+3.58% from price
RSI (14)
54.5
Neutral
MACD (12,26,9)
-1.12
Hist 1.68
ATR (14)
10.45
3.01% of price
Realised vol 30D
52.4%
Annualised
Bollinger upper
366.13
20, 2σ
Bollinger lower
308.59
20, 2σ
50 / 200 cross
Golden
345.35 vs 282.49
Trend bias
Above 200
+22.69%
Risk profile
Beta vs SPY
0.83
Less volatile than market
Correlation to SPY
0.27
Largely independent
Realised vol 30D
52.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-17.3%
Peak to trough
Max drawdown 5Y
-44.5%
Peak to trough
ATR 14
10.45
3.01% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Krystal Biotech Insider Sold Shares Worth $8,227,953, According to a Recent SEC Filing
MT Newswires · 5d ago
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says
MT Newswires · 8d ago
Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More
24/7 Wall St. · 8d ago
RBC Initiates Krystal Biotech at Outperform, With $400 Price Target
MT Newswires · 8d ago
Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript
Motley Fool · 12d ago
Krystal Biotech (KRYS) Stock May Be Fully Valued After Its 5x Run
Simply Wall St. · 12d ago
Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus
Zacks · 18d ago
Krystal Biotech, Inc. Q2 2026 Earnings Call Summary
Moby · 18d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.